ERBB2 and metastatic malignant neoplasm in the lymph nodes: As shown in Table 1, there were no significant differences in age, menopause, lymph node metastasis, distant metastasis, and HER-2 state, between the high SMC4 mRNA expression group and the low SMC4 mRNA expression group (all P values > 0.05).